N-Formyl-Met-Leu-Phe

N-Formyl-Met-Leu-Phe (fMLP; N-Formyl-MLF) is a chemotactic peptide and a specific ligand of N-formyl peptide receptor (FPR). N-Formyl-Met-Leu-Ph is reported to inhibit TNF-alpha secretion.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.
N-Formyl-Met-Leu-Phe(CAS 59880-97-6)

CAT No: R1553

CAS No:59880-97-6

Synonyms/Alias:N-Formyl-Met-Leu-Phe;59880-97-6;FMLP;Chemotactic peptide;fMLF;F-Met-leu-phe;N-Formyl-methionyl-leucyl-phenylalanine;fMetLeuPhe;fMet-Leu-Phe;N-Formyl-L-methionyl-L-leucyl-L-phenylalanine;formyl-Met-Leu-Phe;N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE;(S)-2-((S)-2-((S)-2-Formamido-4-(methylthio)butanamido)-4-methylpentanamido)-3-phenylpropanoic acid;MFCD00036780;CHEMBL267179;CHEBI:53490;(2S)-2-[[(2S)-2-[[(2S)-2-formamido-4-methylsulfanylbutanoyl]amino]-4-methylpentanoyl]amino]-3-phenylpropanoic acid;N-Formyl-MLF;fMLP;N-Formyl-MLF;SMR000857394;LO6AVJ8RCE;Formyl-Met-Leu-Phe-OH;fMLP (misnomer but widely used);NSC-350593;L-Phenylalanine, N-formyl-L-methionyl-L-leucyl-;(2S)-2-(((2S)-2-(((2S)-2-FORMAMIDO-4-METHYLSULFANYLBUTANOYL)AMINO)-4-METHYLPENTANOYL)AMINO)-3-PHENYLPROPANOIC ACID;Formyl met leu phe;Chemotactic peptide?;SCHEMBL39529;MLS001361389;MLS002207097;GTPL1022;DTXSID9041077;GLXC-10556;GLXC-26059;HMS2235B23;HY-P0224;formyl-methionyl-leucyl-phenylalanine;BDBM50050937;F-MET-LEU-PHE L-PHENYLALANINE;AKOS024456858;CS-6489;n-formylmethionine-leucine-phenylalanine;AS-57764;N-Formyl-Met-Leu-Phe, >=97% (HPLC);F1158;D90695;N-(N-(N-FORMYL-L-METHIONYL)-L-LEUCYL);Formyl-Met-Leu-Phe-OH - CAS 59880-97-6;Chemotactic Peptide (For-L-Met-L-Leu-L-Phe-OH);N-Formyl-Met-Leu-Phe, BioXtra, >=99.0% (TLC);Q5090627;(2S)-2-[(2S)-2-[(2S)-2-formamido-4-(methylsulfanyl)butanamido]-4-methylpentanamido]-3-phenylpropanoic acid;(S)-2-((S)-2-((S)-2-Formamido-4-(methylthio)butanamido)-4-methylpentanamido)-3-phenylpropanoicacid;(S)-2-[(S)-2-((S)-2-Formylamino-4-methylsulfanyl-butyrylamino)-4-methyl-pentanoylamino]-3-phenyl-propionic acid;

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C21H31N3O5S
M.W/Mr.
437.6
Sequence
One Letter Code:MLF
Three Letter Code:For-Met-Leu-Phe-OH
Purity
≥98%
Long-term Storage Conditions
Soluble to 4.38 mg/ml in DMSO
Shipping Condition
Shipped at room temperature
InChI
InChI=1S/C21H31N3O5S/c1-14(2)11-17(23-19(26)16(22-13-25)9-10-30-3)20(27)24-18(21(28)29)12-15-7-5-4-6-8-15/h4-8,13-14,16-18H,9-12H2,1-3H3,(H,22,25)(H,23,26)(H,24,27)(H,28,29)/t16-,17-,18-/m0/s1
InChI Key
PRQROPMIIGLWRP-BZSNNMDCSA-N
Canonical SMILES
O=C(O)[C@@H](N([H])C([C@@H](N(C([C@@H](N(C=O)[H])CCSC)=O)[H])CC(C)C)=O)CC1=CC=CC=C1

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Peptide Analysis ServicesCustom Conjugation ServicePeptide Nucleic Acids SynthesisEpitope Mapping ServicescGMP Peptide ServicePeptide Synthesis ServicesPeptide Modification ServicesPeptide CDMO
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers